Tuberculosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adult patients of 18 years and above 2. Evidence of a personally signed and dated informed consent document. 3. All TB patients at initiation of treatment at the participating sites will be included in the study (bacteriologically confirmed TB, clinically diagnosed and extra pulmonary TB)
Exclusion criteria
Exclusion criteria: 1. Patients with CNS TB or TB requiring treatment for more than 6 months 2. Also all patients with documented drug resistant TB will be excluded because their treatment duration is longer than six months and they receive food and financial incentives at the site in Uganda.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TB treatment success defined as the total number of patients in the study arm documented in the TB register as having cured or completed treatment divided by the total number of patients in that study arm. ;TB loss to follow up rate as defined by the total number of TB patients in the study arm documented in the TB register as loss to follow up divided by the total number of patients in that study arm. | — |
Secondary
| Measure | Time frame |
|---|---|
| TB death defined as the total number of patients in the study arm documented in the TB register as having died divided by the total number of patients in that study arm.;TB treatment failure defined as the total number of patients in the study arm documented in the TB register as a treatment failure divided by the total number of patients in that study arm. | — |
Countries
Kenya, Uganda
Contacts
Lecturer Mount Kenya University